Global artificial ventilation and anesthesia masks market size was valued at USD 1,715.3 million in 2014. Key application areas of these masks include operation room, emergency room, intensive care units, and dental rooms for intubation, sedation, and assisted respiratory procedures.
Rising geriatric population prone to various diseases, increasing emergency room procedures, and the growth of home care health services are amongst key drivers attributing to the market growth. Furthermore, availability of various ventilation masks available in the market which include full face masks, nasal masks, hybrid masks, oral masks, and nasal pillows are going to provide patients suffering from sleep apnea with a wide variety of products to choose from thus boosting market growth.
North America artificial ventilation and anesthesia masks market for high-risk procedures by application, 2012-2022, (USD Million)
According to estimates published by the United Nations in 2012, the global geriatric population was nearly 809.4 million and is expected to grow more than double by 2050 to reach an estimated population of over 2,000 million. The growth in geriatric population is a major factor contributing to high prevalence rates of various diseases such as COPD, sleep apnea cancers, coronary artery diseases, kidney failures, and others.
The impact of growing geriatric population on COPD prevalence is very high and as per the WHO estimates, COPD is predicted to be the third leading cause of death worldwide. In the U.S. alone, there were approximately 12.7 million adults aged over 18 who reported to have COPD. Increasing need for emergency treatment for prolonged illnesses and long-term home care treatment associated with lung diseases in children as well as adults are expected to drive the growth of artificial ventilation and anesthesia masks market over the next seven years.
Artificial ventilation and anesthesia masks market is segmented on the basis of application as operation room, intensive care units, emergency room, dental, and home care. Each application segment is classified by risk type as high risk, moderate and low risk. The high risk and moderate risk procedures require intubation and sedation prior to any surgery. The low-risk procedures do not require intubation, however, these ventilation masks are used for oxygen and anesthesia supply to the patient.
The healthcare providers assess the risk to the patient and determine the need to use invasive ventilation or non-invasive ventilation. The use of noninvasive masks in accident and trauma cases, lung failure, and other emergency cases are extremely critical, and quick response is required to save the patient’s life.
In 2014, the operating room accounted for the majority of share of over 87% in high-risk procedures and is expected to maintain its share over the forecast period. Key factors attributing to its large share include growing prevalence of chronic diseases and emergency cases coupled with constantly improving reimbursement scenario which is increasing the demand for surgical procedures are expected to increase the usage rates of ventilation and anesthesia masks over the next seven years.
As per the data published by the U.S. CDC, the National Hospital Discharge Survey in 2010, over 52 million surgical procedures were performed. The number of surgeries performed increases year-on-year due to rapid growth in the geriatric population suffering from various diseases, increase in accidents and others, and as a consequence, usage rates of ventilation masks are expected to witness exponential growth in the next seven years.
North America, Europe, Asia-Pacific, RoW are the key regional markets analyzed in the study. In 2014, North America accounted for the largest share of over 55% in 2014. Key factors attributing to its high share are the presence of high-quality healthcare infrastructure, better reimbursement scenario, and high investment in research and development. Furthermore, technological advancements, high consumer awareness about different treatments available, products and associated benefits are the key forces impacting overall market dynamics
However, Asia Pacific is expected to be the fastest-growing region over the forecast period, mainly due to growth in public and private healthcare facilities, improvement in reimbursement scenario, and increase in the disease prevalence rates.
In the artificial ventilation and anesthesia masks market, Phillips Respironics is the market leader as it has very strong financial performance, wide product portfolio and it also ranks very high on regional penetration. Some of its key products include Wisp, ComfortGel blue nasal mask, amara full view mask, and Easy life CPAP masks.
Key market participants include players such as ResMed, Fisher and Paykel, Ambu, Drager, and CareFusion. Furthermore, increasing technological advancements leading to the development of novel products such as SuperNO2VA by which can be used for the administration of anesthesia, during intubation and assisted breathing process for patients suffering from sleep apnea are expected to further intensify the competition over the forecast period.
The study analyzes ventilation masks which are low-risk class I devices. While these are not technologically complicated devices, recent advancements suggest that manufacturers are now introducing innovations based on patient comfort and safety.
The unique perspective associated with this study encompasses the usage of ventilation masks panned out on the basis of procedure risks. The co-relation between price, features, and procedure risks is analyzed on a deep-dive level and this is likely to help manufacturers gain insights into devising target marketing campaigns. The study also illustrates usage patterns based on procedure sites such as emergency rooms, dental clinics, operation rooms etc. Novel and innovative products that are offered by new entrants in the market are benchmarked and positioned in comparison with existing products.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
A rapid increase in the demand for supplemental oxygen therapy, as a consequence of the Covid-19 outbreak, the artificial ventilation masks market is experiencing a unique challenge of supply shortage. However, the development of makeshift 3D printed masks is catering to this exponential increase in the demand. We at GVR are trying to quantify the impact of this pandemic on the artificial ventilation masks market. Get you to copy now to gain deeper insights on the same.
We value your investment and offer free customization with every report to fulfil your exact research needs.